Exploring human-relevant in vitro and in silico approaches for disease modelling and therapeutic innovation Webinar description BioMed21 (Biomedical Research for the 21st Century Collaboration) invites you to a 60-minute webinar...
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
1 event,
-
Exploring human-relevant in vitro and in silico approaches for disease modelling and therapeutic innovation Webinar description BioMed21 (Biomedical Research for the 21st Century Collaboration) invites you to a 60-minute webinar... |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
1 event,
-
An introduction to HTA, Early HTA, and patient preference evidence for demonstrating the value of repurposed medicines. Repurposing has the potential to bring treatments to patients more quickly and efficiently.... |
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
You can unsubscribe at any time.